封面
市場調查報告書
商品編碼
2148693

神經刺激設備市場:按設備類型、應用程式、最終用戶和地區分類

Neurostimulation Devices Market, By Device Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 255 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,神經刺激設備市場規模將達到69億美元,到2033年將達到142億美元。預計從2026年到2033年,該市場將以10.3%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 69億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 10.30% 2033年市場規模預測: 142億美元

神經刺激設備市場涵蓋了利用電刺激或磁刺激作用於特定神經或神經系統的先進醫療技術。醫療專業人員使用這些設備來治療慢性疼痛、帕金森氏症、癲癇、原發性顫抖、憂鬱症、肌張力不全症和泌尿道功能障礙。主要產品類型包括脊髓刺激設備、深部腦部刺激器、迷走神經刺激設備、薦骨神經刺激器、經顱磁刺激器和經皮電神經刺激系統。這些技術提供標靶性和可調節的治療方案,並在臨床實踐中持續獲得認可。

推動市場擴張的因素眾多,包括神經系統疾病盛行率的上升、人口老化、對微創治療日益成長的需求以及技術的不斷進步。製造商正在開發封閉回路型刺激系統、改進的電池技術、相容於核磁共振成像的設備、更小的植入以及個人化刺激解決方案,以提高治療的精確度和患者的舒適度。醫療服務提供者也受益於醫療成本的上漲、保險覆蓋範圍的擴大以及人們對替代療法的認知度提高。北美仍然是主導市場,但新興的醫療保健系統正在全球創造新的成長機會。

市場動態

隨著醫療機構採用先進療法治療神經系統疾病和慢性疼痛,神經刺激設備的市場正在擴大。帕金森氏症、癲癇、原發性顫抖、憂鬱症、偏頭痛和其他神經系統疾病的盛行率不斷上升,推動了對有效療法的需求。人口老化進一步增加了對這些療法的需求,患者和臨床醫生對微創和非藥物療法的興趣日益濃厚。此外,隨著臨床應用範圍的擴大和人們對神經刺激療法益處的認知不斷提高,醫療機構也開始將神經刺激技術納入其治療方案中。

技術進步持續推動神經刺激設備市場的發展。製造商透過小型化、延長電池壽命、增強核磁共振相容性、實現精準刺激以及封閉回路型技術等方式不斷改進設備設計。這些創新使臨床醫生能夠根據患者的個人需求量身定做治療方案,並有助於提高設備的易用性和治療效果。企業和研究機構也積極探索神經刺激器在疼痛管理、運動障礙、癲癇、憂鬱症和其他神經系統疾病等領域的新應用。對神經科學研究和個人化神經調控投入的增加,正在推動進一步的創新,並擴大潛在的治療機會。

神經刺激設備的廣泛應用面臨許多挑戰。設備和手術的高成本限制了患者獲得治療的機會,尤其是在醫療體系低度開發的國家。有限的保險覆蓋範圍也會加重病患的經濟負擔。此外,植入手術有感染疾病、出血、導線移位和硬體相關問題等併發症風險,這可能會使一些患者放棄治療。嚴格的法規核准要求會延長產品研發週期,而訓練有素的專業人員數量有限也會限制治療的普及。擴大保險覆蓋範圍、加強專業人員培訓以及開發更安全、更經濟的技術將有助於克服這些障礙。

本次調查的主要特點

  • 該研究重點介紹了各個細分市場的潛在商機,並為神經刺激設備市場的相關人員提供了一個有吸引力的投資提案矩陣。
  • 本研究深入分析了市場促進因素、限制因素、機會、新興技術、產品創新、微創治療趨勢、個人化神經調控技術進展、區域展望以及主要市場參與企業採取的競爭策略。
  • 本研究根據公司簡介、產品系列、近期發展、技術進步、財務表現和策略舉措,對神經刺激設備市場的主要參與者進行了分析。
  • 透過利用本報告中提出的見解,醫療保健提供者、醫療設備製造商、投資者、研究人員、技術開發人員和經營團隊可以就產品開發、技術投資、市場擴張、策略合作夥伴關係、臨床應用和神經調控計畫做出明智的決策。
  • 《神經刺激設備市場》報告的目標受眾廣泛,包括投資者、醫療設備製造商、醫療保健提供者、神經科醫生、疼痛管理中心、研究機構、分銷商、技術開發商、新市場參與企業和金融相關人員。
  • 相關人員可以透過「神經刺激設備市場」報告中提出的分析框架、競爭基準、技術評估、市場估值矩陣和區域分析做出明智的策略決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 產品核准
  • 合作關係、併購
  • 監理情勢
  • PEST分析
  • 波特五力分析
  • 流行病學
  • 穩健的管道分析

第4章 全球神經刺激設備市場:依設備類型分類,2021-2033年

  • 深部腦部刺激器
  • 胃電刺激設備
  • 薦骨神經刺激器
  • 迷走神經刺激設備
  • 脊髓刺激設備
  • 其他

第5章 全球神經刺激設備市場:依應用領域分類,2021-2033年

  • 帕金森氏症
  • 憂鬱症
  • 原發性顫抖
  • 尿失禁和糞便失禁
  • 胃輕癱
  • 其他

第6章 全球神經刺激設備市場:依最終用戶分類,2021-2033年

  • 醫院
  • 復健中心
  • 診所

第7章 全球神經刺激設備市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • 熱圖分析
  • 市佔率分析
  • 公司簡介
    • Virtual Medical Centre Inc.
    • Neurosigma
    • Boston Scientific Corporation
    • St. Jude Medical Inc.(Abbott)
    • NDI Medical
    • electroCore LLC
    • Electro Medics
    • Endostim Inc.
    • NeuroPace, Inc.
  • 分析師意見

第9章

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI430

Neurostimulation Devices Market is estimated to be valued at USD 6.9 Bn in 2026 and is expected to reach USD 14.2 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.3% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 6.9 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 10.30% 2033 Value Projection: USD 14.2 Bn

The Neurostimulation Devices Market includes advanced medical technologies that use electrical or magnetic stimulation to target specific nerves or areas of the nervous system. Healthcare providers use these devices to manage chronic pain, Parkinson's disease, epilepsy, essential tremor, depression, dystonia, and urinary disorders. Key product categories include spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, sacral nerve stimulators, transcranial magnetic stimulation devices, and transcutaneous electrical nerve stimulation systems. These technologies offer targeted, adjustable therapy and continue to gain clinical acceptance.

Several factors continue to drive market expansion, including the growing prevalence of neurological disorders, an aging population, rising demand for minimally invasive treatments, and ongoing technological advancements. Manufacturers are developing closed-loop stimulation systems, improved battery technologies, MRI-compatible devices, smaller implants, and personalized stimulation solutions to improve treatment accuracy and patient comfort. Healthcare providers also benefit from rising healthcare spending, broader reimbursement coverage, and greater awareness of alternative therapies. North America remains a major market, while emerging healthcare systems create new growth opportunities worldwide.

Market Dynamics

The Neurostimulation Devices Market is growing as healthcare providers adopt advanced therapies to treat neurological disorders and chronic pain. The increasing incidence of Parkinson's disease, epilepsy, essential tremor, depression, migraine, and other neurological conditions drives demand for effective treatment options. An aging population further increases the need for these therapies, while patients and clinicians show greater interest in minimally invasive and non-pharmacological approaches. Healthcare facilities are also incorporating neurostimulation technologies into treatment programs as clinical applications expand and awareness of their therapeutic benefits increases.

Technological advancements continue to shape the development of the Neurostimulation Devices Market. Manufacturers are enhancing device designs through miniaturization, improved battery life, MRI compatibility, precise stimulation, and closed-loop technologies. These innovations help clinicians customize treatment based on individual patient needs while improving usability and therapeutic outcomes. Companies and research institutions are also exploring new applications in pain management, movement disorders, epilepsy, depression, and other neurological conditions. Growing investments in neuroscience research and personalized neuromodulation further encourage innovation and expand potential treatment opportunities.

Several challenges may limit the wider adoption of neurostimulation devices. High device and procedure costs can restrict access, particularly across developing healthcare systems, while limited reimbursement coverage can increase patients' financial burden. Implantation procedures may also cause complications, including infection, bleeding, lead migration, and hardware-related problems, which can discourage some patients. Regulatory authorities impose strict approval requirements that may extend product development timelines, while limited availability of trained specialists can reduce treatment access. Expanding reimbursement, strengthening professional training, and developing safer, cost-effective technologies can help address these barriers.

Key Features of the Study

  • It highlights potential revenue opportunities across various market segments and provides attractive investment proposition matrices for stakeholders involved in the Neurostimulation Devices Market.
  • This study offers key insights into market drivers, restraints, opportunities, emerging technologies, product innovations, minimally invasive treatment trends, personalized neuromodulation advancements, regional outlook, and competitive strategies adopted by leading market participants.
  • It profiles key players in the Neurostimulation Devices Market based on company overview, product portfolio, recent developments, technological advancements, financial performance, and strategic initiatives.
  • Key companies covered as part of this study include Virtual Medical Centre Inc., Neurosigma, Boston Scientific Corporation, St. Jude Medical Inc. (Abbott), NDI Medical, electroCore LLC, Electro Medics, Endostim Inc., and NeuroPace, Inc.
  • Insights from this report enable healthcare providers, medical device manufacturers, investors, researchers, technology developers, and management teams to make informed decisions regarding product development, technology investments, market expansion, strategic collaborations, clinical applications, and neuromodulation initiatives.
  • The Neurostimulation Devices Market report serves a wide range of stakeholders, including investors, medical device manufacturers, healthcare providers, neurology specialists, pain management centers, research organizations, distributors, technology developers, new market entrants, and financial analysts.
  • Stakeholders can make well-informed strategic decisions through the analytical frameworks, competitive benchmarking, technology assessment, market evaluation matrices, and regional analysis presented in the Neurostimulation Devices Market report.

Market Segmentation

  • By Device type (Revenue, USD Bn, 2021-2033)
    • Deep Brain Stimulators
    • Gastric Electric Stimulators
    • Sacral Nerve Stimulators
    • Vagus Nerve Stimulators
    • Spinal Cord Stimulators
    • Others
  • By Application (Revenue, USD Bn, 2021-2033)
    • Parkinson's Disease
    • Depression
    • Essential Tremor
    • Urinary and Fecal Incontinence
    • Gastroparesis
    • Others
  • By End User (Revenue, USD Bn, 2021-2033)
    • Hospitals
    • Rehabilitation Centers
    • Medical Clinics
  • By Region (Revenue, USD Bn, 2021-2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Key Players
    • Virtual Medical Centre Inc.
    • Neurosigma
    • Boston Scientific Corporation
    • Jude Medical Inc. (Abbott)
    • NDI Medical
    • electroCore LLC
    • Electro Medics
    • Endostim Inc.
    • NeuroPace, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Device Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Approval
  • Collaboration/Merge/Acquisition
  • Regulatory Landscape
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Epidemiology
  • Robust Pipeline Analysis

4. Global Neurostimulation Devices Market, By Device Type, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Deep Brain Stimulators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Gastric Electric Stimulators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Sacral Nerve Stimulators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Vagus Nerve Stimulators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Spinal Cord Stimulators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Global Neurostimulation Devices Market, By Application, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Parkinson's Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Depression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Essential Tremor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Urinary and Fecal Incontinence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Gastroparesis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Neurostimulation Devices Market, By End User, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Rehabilitation Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Medical Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Global Neurostimulation Devices Market, By Region, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profile
    • Virtual Medical Centre Inc.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Neurosigma
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Boston Scientific Corporation
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • St. Jude Medical Inc. (Abbott)
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • NDI Medical
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • electroCore LLC
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Electro Medics
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Endostim Inc.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • NeuroPace, Inc.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us